Pharmaceutical Composition for Oral Administration Comprising Aminopyrimidine Derivative or Pharmaceutically Acceptable Salt, Hydrate, or Solvate Thereof
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- JANSSEN BIOTECH, INC., Horsham, Pennsylvania has been assigned a patent (No. US 12138351 B2, initially filed April 13, 2021) developed by Jacqueline Maximilien, Antwerp, Belgium, and Gopal Rajan, Antwerp, Belgium, for "Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharmaceutically acceptable salt, hydrate, or solvate thereof." . . .